AbbVie Partnering Day


Thu, April 24, 10:00 – 18:00


San Mateo Marriot - 1770 South Amphlett Blvd., San Mateo, CA 94402




AbbVie has the expertise of a proven pharmaceutical leader and the focus and passion of a biotech. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe. AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott.

AbbVie partnerships are dedicated to two important outcomes: developing innovative new medicines and delivering a remarkable impact on peoples’ lives. AbbVie takes a highly strategic approach to developing these partnerships with a goal to create long-term mutually beneficial relationships. A passion for translating science into effective medicine and a shared vision for a successful outcome are important foundations for AbbVie partnerships.

This AbbVie Partnering Day is focused on a core set of therapeutic areas where the company has proven expertise and where AbbVie believes it can have an even greater impact on the disease and how it is managed.

Confirmed AbbVie Participants

  • Jim Sullivan
    Vice President, Discovery
  • John Poulos
    Vice President, Licensing & Acquisition
  • Anna Maroney
    Vice President, Alliance Management
  • David Donabedian
    Vice President, Ventures and Early Stage Collaborations Kevin Lynch
  • Vice President, Scientific Assessment
  • Anil Singhal
    Vice President, AbbVie Biotherapeutics*
  • Alberto Zacarias
    Senior Director, Innovation, AbbVie Biotherapeutics*
  • Michelle Calhoun
    Director, CMO Sales & Marketing

*AbbVie Biotherapeutics is Abbvie’s biotech located in the San Francisco Bay Area.

What: AbbVie Partnering Day

When: Thursday, April 24, 2014

One-on-one Meetings
(application required)


Plenary Session
AbbVie: Partner of Choice and Corporate Overview
(open admission)

Networking Reception
(open admission)

For More Information